Skip to main content
Erschienen in: Endocrine 2/2016

30.07.2016 | Original Article

Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome

verfasst von: Cristina Guillín-Amarelle, Sofía Sánchez-Iglesias, Ana Castro-Pais, Leticia Rodriguez-Cañete, Lucía Ordóñez-Mayán, Marcos Pazos, Blanca González-Méndez, Silvia Rodríguez-García, Felipe F. Casanueva, Ana Fernández-Marmiesse, David Araújo-Vilar

Erschienen in: Endocrine | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Familial partial lipodystrophy are Mendelian disorders involving abnormal body fat distribution and insulin resistance. The current classification includes the Köbberling syndrome (type 1 familial partial lipodystrophy), characterized by fat loss in the lower limbs and abnormal fat accumulation in other areas. Type 1 familial partial lipodystrophy appears to be heritable, but little is known about it, including putative contributing mutations. We aimed to characterize this syndrome better by evaluating a group of women with phenotypic features of type 1 familial partial lipodystrophy. This is a case-controlled study in which 98 women with type 1 familial partial lipodystrophy that lacked classical mutations known to cause familial partial lipodystrophy were compared with 60 women without lipodystrophy and 25 patients with type 2 familial partial lipodystrophy (Dunnigan disease). Clinical course, body composition by dual-energy X-ray absorptiometry, HbA1c, lipid profile, insulin, leptin and family history were evaluated in all of the participants. Analyses of receiver-operating characteristic curve were performed for type 1 familial partial lipodystrophy diagnosis, comparing different truncal/limbs ratios. Among patients with type 1 familial partial lipodystrophy, 68 % developed recognizable lipodystrophy before adolescence, and most displayed an autosomal-dominant pattern (86 %). Women with type 1 familial partial lipodystrophy had less lower-limb adipose tissue than women without lipodystrophy, but significantly more than patients with Dunnigan disease. Moreover, metabolic disturbances occurred more frequently in the type 1 familial partial lipodystrophy group (81 %) than in the non-lipodystrophic group (30 %, p<0.05). The severity of metabolic disturbances was inversely proportional to the percentage of fat in the lower extremities and directly proportional to the amount of visceral adipose tissue. Metabolic profiles were worse in type 1 familial partial lipodystrophy than in Dunnigan disease. According to the receiver-operating characteristic curve analysis, the best ratio was subscapular/calf skinfolds (KöB index), with a cut-off value of 3.477 (sensitivity: 89 %; specificity: 84 %). Type 1 familial partial lipodystrophy was an early-onset, autosomal-dominant lipodystrophy, characterized by fat loss in the lower limbs and abnormal fat accumulation in the abdominal visceral region, associated to insulin resistance and metabolic disorders. A KöB index >3.477 is highly suggestive of this syndrome.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat H. Cao, R.A. Hegele, Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9, 109–112 (2000)CrossRefPubMed H. Cao, R.A. Hegele, Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum. Mol. Genet. 9, 109–112 (2000)CrossRefPubMed
2.
Zurück zum Zitat I. Barroso, M. Gurnell, V.E. Crowley, M. Agostini, J.W. Schwabe, M.A. Soos et al., Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880–883 (1999)PubMed I. Barroso, M. Gurnell, V.E. Crowley, M. Agostini, J.W. Schwabe, M.A. Soos et al., Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402, 880–883 (1999)PubMed
3.
Zurück zum Zitat A.K. Agarwal, A. Garg, A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J. Clin. Endocrinol. Metab. 87, 408–411 (2002)PubMed A.K. Agarwal, A. Garg, A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy. J. Clin. Endocrinol. Metab. 87, 408–411 (2002)PubMed
4.
Zurück zum Zitat K. Tan, W.A. Kimber, J. Luan, M.A. Soos, R.K. Semple, N.J. Wareham, S. O’Rahilly, I. Barroso, Analysis of genetic variation in Akt2/PKB-beta in severe insulin resistance, lipodystrophy, type 2 diabetes, and related metabolic phenotypes. Diabetes 56, 714–719 (2007)CrossRefPubMedPubMedCentral K. Tan, W.A. Kimber, J. Luan, M.A. Soos, R.K. Semple, N.J. Wareham, S. O’Rahilly, I. Barroso, Analysis of genetic variation in Akt2/PKB-beta in severe insulin resistance, lipodystrophy, type 2 diabetes, and related metabolic phenotypes. Diabetes 56, 714–719 (2007)CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat O. Rubio-Cabezas, V. Puri, I. Murano, V. Saudek, R.K. Semple, S. Dash et al., Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. Embo. Mol. Med. 1, 280–287 (2009)CrossRefPubMedPubMedCentral O. Rubio-Cabezas, V. Puri, I. Murano, V. Saudek, R.K. Semple, S. Dash et al., Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. Embo. Mol. Med. 1, 280–287 (2009)CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat S. Gandotra, C. Le Dour, W. Bottomley, P. Cervera, P. Giral, Y. Reznik et al., Perilipin deficiency and autosomal dominant partial lipodystrophy. N. Engl. J. Med. 364, 740–748 (2011)CrossRefPubMedPubMedCentral S. Gandotra, C. Le Dour, W. Bottomley, P. Cervera, P. Giral, Y. Reznik et al., Perilipin deficiency and autosomal dominant partial lipodystrophy. N. Engl. J. Med. 364, 740–748 (2011)CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat S.M. Farhan, J.F. Robinson, A.D. McIntyre, M.G. Marrosu, A.F. Ticca, S. Loddo et al., A novel LIPE nonsense mutation found using exome sequencing in siblings with late-onset familial partial lipodystrophy. Can. J. Cardiol. 30, 1649–1654 (2014)CrossRefPubMed S.M. Farhan, J.F. Robinson, A.D. McIntyre, M.G. Marrosu, A.F. Ticca, S. Loddo et al., A novel LIPE nonsense mutation found using exome sequencing in siblings with late-onset familial partial lipodystrophy. Can. J. Cardiol. 30, 1649–1654 (2014)CrossRefPubMed
8.
Zurück zum Zitat K.L. Herbst, L.R. Tannock, S.S. Deeb, J.Q. Purnell, J.D. Brunzell, A. Chait, Kobberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care 26, 1819–1824 (2003)CrossRefPubMed K.L. Herbst, L.R. Tannock, S.S. Deeb, J.Q. Purnell, J.D. Brunzell, A. Chait, Kobberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care 26, 1819–1824 (2003)CrossRefPubMed
9.
Zurück zum Zitat A. Garg, R.M. Peshock, J.L. Fleckenstein, Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 84, 170–174 (1999)PubMed A. Garg, R.M. Peshock, J.L. Fleckenstein, Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 84, 170–174 (1999)PubMed
10.
Zurück zum Zitat T.P. Nedungadi, D.J. Clegg, Sexual dimorphism in body fat distribution and risk for cardiovascular diseases. J. Cardiovasc. Transl. Res. 2, 321–327 (2009)CrossRefPubMed T.P. Nedungadi, D.J. Clegg, Sexual dimorphism in body fat distribution and risk for cardiovascular diseases. J. Cardiovasc. Transl. Res. 2, 321–327 (2009)CrossRefPubMed
11.
Zurück zum Zitat B. Donadille, O. Lascols, J. Capeau, C. Vigouroux, Etiological investigations in apparent type 2 diabetes: when to search for lamin A/C mutations? Diabetes & Metabolism 31, 527–532 (2005)CrossRef B. Donadille, O. Lascols, J. Capeau, C. Vigouroux, Etiological investigations in apparent type 2 diabetes: when to search for lamin A/C mutations? Diabetes & Metabolism 31, 527–532 (2005)CrossRef
12.
Zurück zum Zitat D. Araujo-Vilar, L. Loidi, F. Dominguez, J. Cabezas-Cerrato, Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation. Horm. Metab. Res. 35, 29–35 (2003)CrossRefPubMed D. Araujo-Vilar, L. Loidi, F. Dominguez, J. Cabezas-Cerrato, Phenotypic gender differences in subjects with familial partial lipodystrophy (Dunnigan variety) due to a nuclear lamin A/C R482W mutation. Horm. Metab. Res. 35, 29–35 (2003)CrossRefPubMed
13.
Zurück zum Zitat R.A. Hegele, C.M. Anderson, J. Wang, D.C. Jones, H. Cao, Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res. 10, 652–658 (2000)CrossRefPubMedPubMedCentral R.A. Hegele, C.M. Anderson, J. Wang, D.C. Jones, H. Cao, Association between nuclear lamin A/C R482Q mutation and partial lipodystrophy with hyperinsulinemia, dyslipidemia, hypertension, and diabetes. Genome Res. 10, 652–658 (2000)CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat A. Garg, Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 85, 1776–1782 (2000)PubMed A. Garg, Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety). J. Clin. Endocrinol. Metab. 85, 1776–1782 (2000)PubMed
15.
Zurück zum Zitat G. Bidault, M. Garcia, M.C. Vantyghem, P.H. Ducluzeau, R. Morichon, K. Thiyagarajah et al., Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 33, 2162–2171 (2013)CrossRefPubMed G. Bidault, M. Garcia, M.C. Vantyghem, P.H. Ducluzeau, R. Morichon, K. Thiyagarajah et al., Lipodystrophy-linked LMNA p.R482W mutation induces clinical early atherosclerosis and in vitro endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 33, 2162–2171 (2013)CrossRefPubMed
16.
Zurück zum Zitat M.C. Vantyghem, D. Vincent-Desplanques, F. Defrance-Faivre, J. Capeau, C. Fermon, A.S. Valat et al., Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy. J. Clin. Endocrinol. Metab. 93, 2223–2229 (2008)CrossRefPubMed M.C. Vantyghem, D. Vincent-Desplanques, F. Defrance-Faivre, J. Capeau, C. Fermon, A.S. Valat et al., Fertility and obstetrical complications in women with LMNA-related familial partial lipodystrophy. J. Clin. Endocrinol. Metab. 93, 2223–2229 (2008)CrossRefPubMed
17.
Zurück zum Zitat H.F. Escobar-Morreale, J.L. San Millan, Abdominal adiposity and the polycystic ovary syndrome. Trends. Endocrinol. Metab. 18, 266–272 (2007)CrossRefPubMed H.F. Escobar-Morreale, J.L. San Millan, Abdominal adiposity and the polycystic ovary syndrome. Trends. Endocrinol. Metab. 18, 266–272 (2007)CrossRefPubMed
18.
Zurück zum Zitat M.G. Dunnigan, M.A. Cochrane, A. Kelly, J.W. Scott, Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Q. J. Med. 43, 33–48 (1974)PubMed M.G. Dunnigan, M.A. Cochrane, A. Kelly, J.W. Scott, Familial lipoatrophic diabetes with dominant transmission. A new syndrome. Q. J. Med. 43, 33–48 (1974)PubMed
19.
Zurück zum Zitat J. Kobberling, B. Willms, R. Kattermann, W. Creutzfeldt, Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetes. Humangenetik 29, 111–120 (1975)PubMed J. Kobberling, B. Willms, R. Kattermann, W. Creutzfeldt, Lipodystrophy of the extremities. A dominantly inherited syndrome associated with lipatrophic diabetes. Humangenetik 29, 111–120 (1975)PubMed
20.
Zurück zum Zitat J. Kobberling, M.G. Dunnigan, Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state. J. Med. Genet. 23, 120–127 (1986)CrossRefPubMedPubMedCentral J. Kobberling, M.G. Dunnigan, Familial partial lipodystrophy: two types of an X linked dominant syndrome, lethal in the hemizygous state. J. Med. Genet. 23, 120–127 (1986)CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat S.N. Jackson, T.A. Howlett, P.G. McNally, S. O’Rahilly, R.C. Trembath, Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy. Q. J. Med. 90, 27–36 (1997)CrossRef S.N. Jackson, T.A. Howlett, P.G. McNally, S. O’Rahilly, R.C. Trembath, Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy. Q. J. Med. 90, 27–36 (1997)CrossRef
22.
Zurück zum Zitat M.S. Treuth, G.R. Hunter, T. Kekes-Szabo, Estimating intraabdominal adipose tissue in women by dual-energy X-ray absorptiometry. Am. J. Clin. Nutr. 62, 527–32 (1995)PubMed M.S. Treuth, G.R. Hunter, T. Kekes-Szabo, Estimating intraabdominal adipose tissue in women by dual-energy X-ray absorptiometry. Am. J. Clin. Nutr. 62, 527–32 (1995)PubMed
23.
Zurück zum Zitat J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1990) J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1990)
24.
Zurück zum Zitat J.C. Levy, D.R. Matthews, M.P. Hermans, Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21, 2191–2192 (1998)CrossRefPubMed J.C. Levy, D.R. Matthews, M.P. Hermans, Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21, 2191–2192 (1998)CrossRefPubMed
25.
Zurück zum Zitat D.W. Hosmer, S. Lemeshow, E. Cook, Applied Logistic Regression. 2nd ed. John Wiley & Sons, New York, NY (2000)CrossRef D.W. Hosmer, S. Lemeshow, E. Cook, Applied Logistic Regression. 2nd ed. John Wiley & Sons, New York, NY (2000)CrossRef
26.
Zurück zum Zitat A.D. Bohr, K. Laurson, M.B. McQueen, A novel cutoff for the waist-to-height ratio predicting metabolic syndrome in young American adults. BMC Public Health 16, 295 (2016)CrossRefPubMedPubMedCentral A.D. Bohr, K. Laurson, M.B. McQueen, A novel cutoff for the waist-to-height ratio predicting metabolic syndrome in young American adults. BMC Public Health 16, 295 (2016)CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat M.B. Snijder, J.M. Dekker, M. Visser, L.M. Bouter, C.D. Stehouwer, P.J. Kostense et al., Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am. J. Clin. Nutr. 77, 1192–1197 (2003)PubMed M.B. Snijder, J.M. Dekker, M. Visser, L.M. Bouter, C.D. Stehouwer, P.J. Kostense et al., Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am. J. Clin. Nutr. 77, 1192–1197 (2003)PubMed
28.
Zurück zum Zitat S. Yusuf, S. Hawken, S. Ounpuu, L. Bautista, M.G. Franzosi, P. Commerford et al., Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366, 1640–1649 (2005)CrossRefPubMed S. Yusuf, S. Hawken, S. Ounpuu, L. Bautista, M.G. Franzosi, P. Commerford et al., Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366, 1640–1649 (2005)CrossRefPubMed
Metadaten
Titel
Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome
verfasst von
Cristina Guillín-Amarelle
Sofía Sánchez-Iglesias
Ana Castro-Pais
Leticia Rodriguez-Cañete
Lucía Ordóñez-Mayán
Marcos Pazos
Blanca González-Méndez
Silvia Rodríguez-García
Felipe F. Casanueva
Ana Fernández-Marmiesse
David Araújo-Vilar
Publikationsdatum
30.07.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2016
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1002-x

Weitere Artikel der Ausgabe 2/2016

Endocrine 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.